GB201515718D0 - Method - Google Patents

Method

Info

Publication number
GB201515718D0
GB201515718D0 GBGB1515718.3A GB201515718A GB201515718D0 GB 201515718 D0 GB201515718 D0 GB 201515718D0 GB 201515718 A GB201515718 A GB 201515718A GB 201515718 D0 GB201515718 D0 GB 201515718D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1515718.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aslan Pharmaceuticals Pte Ltd
Original Assignee
Aslan Pharmaceuticals Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aslan Pharmaceuticals Pte Ltd filed Critical Aslan Pharmaceuticals Pte Ltd
Priority to GBGB1515718.3A priority Critical patent/GB201515718D0/en
Publication of GB201515718D0 publication Critical patent/GB201515718D0/en
Priority claimed from US15/757,133 external-priority patent/US10357494B2/en
Priority claimed from US16/134,736 external-priority patent/US20190117655A1/en
Ceased legal-status Critical Current

Links

GBGB1515718.3A 2015-09-04 2015-09-04 Method Ceased GB201515718D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1515718.3A GB201515718D0 (en) 2015-09-04 2015-09-04 Method

Applications Claiming Priority (22)

Application Number Priority Date Filing Date Title
GBGB1515718.3A GB201515718D0 (en) 2015-09-04 2015-09-04 Method
US15/757,133 US10357494B2 (en) 2015-09-04 2016-09-05 Combination therapy comprising varlitinib and an anticancer agent
JP2018511204A JP2018535923A (en) 2015-09-04 2016-09-05 Treatment of biliary tract cancer
JP2018511230A JP2018526382A (en) 2015-09-04 2016-09-05 Valritinib for the treatment of resistant or refractory cancer
EP16774458.0A EP3344251B1 (en) 2015-09-04 2016-09-05 A combination therapy comprising varlitinib and an anticancer agent
CN201680049587.2A CN108135901A (en) 2015-09-04 2016-09-05 the treatment of cholangiocarcinoma
PCT/EP2016/070888 WO2017037298A1 (en) 2015-09-04 2016-09-05 A combination therapy comprising varlitinib and an anticancer agent
KR1020187008555A KR20180048804A (en) 2015-09-04 2016-09-05 Combination therapy with baritinib and anticancer drugs
CN201680048795.0A CN108025010A (en) 2015-09-04 2016-09-05 Giovanni for treating drug resistance or intractable cancer replaces Buddhist nun
JP2018511226A JP2018526381A (en) 2015-09-04 2016-09-05 Combination therapy comprising valritinib and an anticancer drug
PCT/EP2016/070874 WO2017037292A1 (en) 2015-09-04 2016-09-05 Combination of a dhodh inhibitor and a her inhibitor for use in the treatment of cancer
PCT/EP2016/070893 WO2017037300A1 (en) 2015-09-04 2016-09-05 Varlitinib for use in the treatment of resistant or refractory cancer
KR1020187008556A KR20180043356A (en) 2015-09-04 2016-09-05 Treatment of cholangiocarcinoma
EP16774460.6A EP3344253B1 (en) 2015-09-04 2016-09-05 Varlitinib for use in the treatment of resistant or refractory cancer
CN201680048536.8A CN108135900A (en) 2015-09-04 2016-09-05 Comprising Giovanni for Buddhist nun and the combination treatment of anticancer agent
US15/757,166 US20180353510A1 (en) 2015-09-04 2016-09-05 Treatment of Biliary Duct Cancer
US15/757,189 US10682353B2 (en) 2015-09-04 2016-09-05 Varlitinib for use in the treatment of resistant or refractory cancer
EP16774459.8A EP3344252B1 (en) 2015-09-04 2016-09-05 Treatment of biliary duct cancer
PCT/EP2016/070890 WO2017037299A1 (en) 2015-09-04 2016-09-05 Treatment of biliary duct cancer
ES16774460T ES2788162T3 (en) 2015-09-04 2016-09-05 Varlitinib for use in the treatment of resistant or refractory cancer
US16/134,736 US20190117655A1 (en) 2015-09-04 2018-09-18 Treatment of Biliary Duct Cancer
US16/508,444 US10849899B2 (en) 2015-09-04 2019-07-11 Combination therapy comprising Varlitinib and an anticancer agent

Publications (1)

Publication Number Publication Date
GB201515718D0 true GB201515718D0 (en) 2015-10-21

Family

ID=54345792

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1515718.3A Ceased GB201515718D0 (en) 2015-09-04 2015-09-04 Method

Country Status (1)

Country Link
GB (1) GB201515718D0 (en)

Similar Documents

Publication Publication Date Title
GB201516047D0 (en) Method
GB201502645D0 (en) Method
GB201502810D0 (en) Method
GB201518263D0 (en) Method
GB201506870D0 (en) Method
GB201501941D0 (en) Method
GB201506869D0 (en) Method
GB201501565D0 (en) Method
GB201500427D0 (en) Method
GB201518465D0 (en) Method
GB201516056D0 (en) Method
GB201509961D0 (en) Method
GB201510649D0 (en) Method
GB201507581D0 (en) Method
GB201503792D0 (en) Method
GB201502409D0 (en) Method
GB201518850D0 (en) Method
GB201517618D0 (en) Method
GB201517634D0 (en) Method
GB201517450D0 (en) Method
GB201517386D0 (en) Method
GB201515921D0 (en) Method
GB201515711D0 (en) Method
GB201515746D0 (en) Method
GB201515716D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)